WC
MR

Wexford Capital’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Wexford Capital’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,502
Closed -$287K – 89
2015
Q1 		$287K Buy
+10,502
New +$289K 0.08% 60

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CCMH
Cornerstone Capital Management Holdings New York $14.3B AUM 33.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wexford Capital's MR Position: Q2 2015 in Review

Wexford Capital sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2015, closing a stake of 10,502 shares — an estimated $287K sold.

Wexford Capital first reported a position in MR in Q1 2015 and held it in 1 quarter. The position peaked at $287K in Q1 2015. 118 funds tracked by Wall St. Rank hold MR as of Q2 2015.

  • Wexford Capital reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2015 after selling out during the quarter.
  • Wexford Capital sold 10,502 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2015, an estimated $287K.
  • Wexford Capital first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q1 2015 and held it in 1 quarter.
  • Wexford Capital's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $287K in Q1 2015.
  • 118 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2015.

Based on Wexford Capital's 13F filing for Q2 2015, filed 12 Aug 2015.